FLGT Q4 2025 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

Q4 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$83M+9.3% YoY

Gross Profit

$33M39.1% margin

Operating Income

-$36M-43.5% margin

Net Income

-$23M-28.1% margin

EPS (Diluted)

$-0.76

QoQ Revenue Growth

-0.9%

Cash Flow

Operating Cash Flow

-$78M

Free Cash Flow

-$83M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$107M

Stockholders' Equity

$1.1B

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$83M	$76M	+9.3%
Gross Profit	$33M	$32M	+2.3%
Operating Income	-$36M	-$16M	-124.6%
Net Income	-$23M	-$6M	-297.7%

Revenue Segments

Laboratory Services

$83M100%

Geographic Segments

Non-US

$8M50%

CHINA

$5M28%

Other Countries

$4M22%